Insulet Corp PODD:NASDAQ

RT Quote | NASDAQ | USD

Last | 03/04/21 EST

242.36

-10.74 (-4.24%)

Volume

601,257

52 week range

121.00 - 298.43

...

Loading . . .

KEY STATS

Open250.32
Day High254.10
Day Low240.06
Prev Close242.36
52 Week High298.43
52 Week High Date01/20/21
52 Week Low121.00
52 Week Low Date03/18/20
Market Cap16.015B
Shares Out66.08M
10 Day Average Volume0.51M
Dividend-
Dividend Yield-
Beta0.65
1 Year % Change35.36

RATIOS/PROFITABILITY

EPS (TTM)0.10
P/E (TTM)2,411.54
Fwd P/E (NTM)439.85
EBITDA (MRQ)106.90M
ROE (MRQ)2.00%
Revenue (MRQ)904.40M
Gross Margin (MRQ)64.39%
Net Margin (MRQ)0.75%
Debt To Equity (MRQ)175.50%

EVENTS

Earnings Date05/05/2021
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest Insulet Corp News

There is no recent news for this security.

Latest PODD News From Our Partners

February 23, 2021

Insulet Corporation (PODD) CEO Shacey Petrovic on Q4 2020 Results - Earnings Call Transcript Seeking Alpha

February 22, 2021

Insulet Q4 2020 Earnings Preview Seeking Alpha

February 22, 2021

Notable earnings after Tuesday's close Seeking Alpha

QUOTE FINDER

Market Movers

Profile

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that...

Timothy Scannell

Chairman

Shacey Petrovic

President

Charles Alpuche

Chief Operating Officer

Wayde McMillan

Chief Financial Officer

Bret Christensen

Executive Vice President

Address

100 Nagog Park

Acton, MA

01720-3440

United States

https://www.myomnipod.com